US BANCORP \DE\ - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 111 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$35,550
-42.8%
773
-28.5%
0.00%
Q2 2023$62,125
-50.7%
1,081
-67.8%
0.00%
Q1 2023$125,926
+36.2%
3,358
+1.8%
0.00%
Q4 2022$92,466
+32.1%
3,300
+32.4%
0.00%
Q3 2022$70,0000.0%2,492
+23.2%
0.00%
Q2 2022$70,000
+42.9%
2,023
+49.5%
0.00%
Q1 2022$49,000
+58.1%
1,353
+3.3%
0.00%
Q4 2021$31,000
+40.9%
1,310
+12.8%
0.00%
Q3 2021$22,000
-4.3%
1,1610.0%0.00%
Q2 2021$23,000
+9.5%
1,1610.0%0.00%
Q1 2021$21,000
-12.5%
1,161
-2.6%
0.00%
Q4 2020$24,000
+4.3%
1,1920.0%0.00%
Q3 2020$23,000
-68.9%
1,192
-63.8%
0.00%
Q2 2020$74,000
+335.3%
3,294
+183.7%
0.00%
Q1 2020$17,000
-37.0%
1,161
-17.0%
0.00%
Q4 2019$27,000
+800.0%
1,398
+898.6%
0.00%
Q1 2019$3,000
-98.1%
140
-98.5%
0.00%
-100.0%
Q2 2015$159,000
+12.8%
9,055
-3.6%
0.00%0.0%
Q1 2015$141,000
+20.5%
9,395
-6.6%
0.00%
Q4 2014$117,00010,0600.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders